← Open Payments lookup

CAITLIN STORK: Open Payments

NPI 1275254542 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,023 in 122 payments from 23 companies in 2025. Trend: 2023 $3,327 · 2024 $2,754 · 2025 $2,023

Food & beverage: $2,023
CompanyPaymentsAmount
Novo Nordisk Inc15$328
ABBVIE INC.19$301
Lilly USA, LLC12$257
AstraZeneca Pharmaceuticals LP10$219
Amgen Inc.25$188
Xeris Pharmaceuticals, Inc.5$93
Dexcom, Inc.4$90
GlaxoSmithKline, LLC.5$80
Bayer Healthcare Pharmaceuticals Inc.4$75
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$59

Products named: VRAYLAR, MOUNJARO, Ozempic, OTEZLA, FARXIGA, AIRSUPRA, Wegovy, GVOKE HYPOPEN.

Industry payments across TX — which companies pay providers there.